Clinical Trial

Long-term Safety of UC-MSC Transplantation in Patients With Retinitis Pigmentosa

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The study will perform to follow-up UC-MSCs and CM transplantation. 18 patients will be called back to be examined after 5 years of UC-MSC and/or CM transplantation.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-03-14; most recent amendment 2026-02-23.
Status change: Enrolling by Invitation → Not Yet Recruiting 2026-02-23
Trial Details
NCT Number NCT05786287
Lead Sponsor PT. Prodia Stem Cell Indonesia
Conditions Retinitis Pigmentosa
Enrollment 18 participants
Start Date 2026-05
Primary Completion 2027-07 (estimated)
Study Completion 2027-09 (estimated)
Updated on ClinicalTrials.gov 2026-02-25